Coreline AVIEW (Lung CT AI)
Save to shortlistCovers: lung nodule detection, emphysema quantification, airway disease quantification
Last reviewed Nov 9, 2026 against the sources listed on this page · How we review
At a glance
AVIEW from Coreline Soft is an FDA-cleared AI platform for chest CT analysis, with modules for automated lung-nodule detection and characterization (AVIEW LCS/LCS Plus) as well as quantification…
- FDA:
- 510(k) K251203 +2 more
- Epic:
- Not on record
- Named users:
- 3 named in public reports
- Published study:
- Not on record
Description
AVIEW from Coreline Soft is an FDA-cleared AI platform for chest CT analysis, with modules for automated lung-nodule detection and characterization (AVIEW LCS/LCS Plus) as well as quantification of emphysema and airway disease (AVIEW COPD). The suite supports lung-cancer screening programs and quantitative respiratory-disease assessment, and has received multiple FDA 510(k) clearances (e.g., K221592, K214036, K243689). Coreline Soft is headquartered in Seoul, South Korea.
Quick answers
Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review
- Is Coreline AVIEW (Lung CT AI) FDA cleared?
- The public FDA database has 3 records that our team matched to Coreline AVIEW (Lung CT AI). The most recent is 510(k) K251203 (AVIEW Lung Nodule CAD), decided Dec 2025. Check that the cleared use matches how you plan to use it.FDA record K251203
- Which health systems use Coreline AVIEW (Lung CT AI)?
- Linked public reports name 3 organizations: Charité – Universitätsmedizin Berlin, Klinikum Chemnitz and Seoul Metropolitan Government Boramae Medical Center. "Who's using this" below lists them all, plus any the maker reports. Ask the vendor for a reference at an organization like yours.Charité – Universitätsmedizin Berlin (PR Newswire) Klinikum Chemnitz (Coreline Soft) Seoul Metropolitan Government Boramae Medical Center (Coreline Soft)
Security & contracting
The maker has not reported these details yet. Ask the vendor directly during evaluation.
- Workflow stage
- Not reported
- Integrations
- Not reported
- Data inputs
- Not reported
- Deployment
- Not reported
- Signs a BAA
- Not reported
- SOC 2 report
- Not reported
- HITRUST
- Not reported
- Evidence type
- Not assessed
Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.
Who's using this
3 organizationsOrganizations named in public announcements or by the developer. Inclusion is not an endorsement.
Charité – Universitätsmedizin Berlin
“Coreline Soft supplies lung cancer screening AI to Charité” — PR Newswire, Mar 2026Seoul Metropolitan Government Boramae Medical Center
“Boramae Medical Center adopts AVIEW chest AI” — Coreline Soft, Aug 2025
Last checked Nov 9, 2026. Spot an error? Let us know through the discussion below.
Get weekly updates for Pulmonology
Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.
Sources
This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.
WebsiteFDA database records
- K251203 · 510(k) · Dec 2025AVIEW Lung Nodule CAD
- K221592 · 510(k) · Feb 2023AVIEW Lung Nodule CAD
- K193220 · 510(k) · May 2020AVIEW LCS
Matched by our team from the public FDA database; checked Nov 10, 2026.
History (7)Show
Dated events on this listing's public record, newest first.
- Sep 13, 2026
Added to CIFoundry
- Mar 23, 2026
News report names Charité – Universitätsmedizin Berlin as a user (PR Newswire)source
- Dec 3, 2025
FDA 510(k) K251203 decision datesource
- Oct 23, 2025
News report names Klinikum Chemnitz as a user (Coreline Soft)source
- Aug 12, 2025
News report names Seoul Metropolitan Government Boramae Medical Center as a user (Coreline Soft)source
- Feb 24, 2023
FDA 510(k) K221592 decision datesource
- May 5, 2020
FDA 510(k) K193220 decision datesource
Developer
Coreline Soft Co., Ltd.
Evaluating this tool?
Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.
Prepare evaluation packetChecklist for your role: Admin · Physician · IT · Compliance
Compare similar tools →